Figure 7
From: Dose-dense adjuvant chemotherapy for primary breast cancer
Memorial Sloan-Kettering Cancer Center Pilot trial of epirubicin and cyclophosphamide followed by paclitaxel at 10–11 day intervals. G-CSF, granulocyte colony-stimulating factor.
